Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1994 1
1996 1
2000 1
2003 1
2004 4
2005 1
2006 1
2007 1
2008 4
2009 7
2010 1
2011 3
2012 2
2013 3
2014 1
2015 8
2016 2
2017 9
2018 7
2019 7
2020 10
2021 5
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

PubMed for id: 1771720

88 results

Results by year

Filters applied: . Clear all
Page 1
A platform-independent AI tumor lineage and site (ATLAS) classifier.
Rydzewski NR, Shi Y, Li C, Chrostek MR, Bakhtiar H, Helzer KT, Bootsma ML, Berg TJ, Harari PM, Floberg JM, Blitzer GC, Kosoff D, Taylor AK, Sharifi MN, Yu M, Lang JM, Patel KR, Citrin DE, Sundling KE, Zhao SG. Rydzewski NR, et al. Commun Biol. 2024 Mar 13;7(1):314. doi: 10.1038/s42003-024-05981-5. Commun Biol. 2024. PMID: 38480799 Free PMC article.
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.
Duke ES, Bradford D, Marcovitz M, Amatya AK, Mishra-Kalyani PS, Nguyen E, Price LSL, Fourie Zirkelbach J, Li Y, Bi Y, Kraft J, Dorff SE, Scepura B, Stephenson M, Ojofeitimi I, Nair A, Han Y, Tezak Z, Lemery SJ, Pazdur R, Larkins E, Singh H. Duke ES, et al. Clin Cancer Res. 2023 Sep 15;29(18):3573-3578. doi: 10.1158/1078-0432.CCR-23-0459. Clin Cancer Res. 2023. PMID: 37265412 Free PMC article. Clinical Trial.
88 results